Paclitaxel - 25021-213-17 - (paclitaxel)

Alphabetical Index


Drug Information of Paclitaxel

Product NDC: 25021-213
Proprietary Name: Paclitaxel
Non Proprietary Name: paclitaxel
Active Ingredient(s): 6    mg/mL & nbsp;   paclitaxel
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Paclitaxel

Product NDC: 25021-213
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090130
Marketing Category: ANDA
Start Marketing Date: 20110927

Package Information of Paclitaxel

Package NDC: 25021-213-17
Package Description: 1 VIAL in 1 CARTON (25021-213-17) > 16.7 mL in 1 VIAL

NDC Information of Paclitaxel

NDC Code 25021-213-17
Proprietary Name Paclitaxel
Package Description 1 VIAL in 1 CARTON (25021-213-17) > 16.7 mL in 1 VIAL
Product NDC 25021-213
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name paclitaxel
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20110927
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name PACLITAXEL
Strength Number 6
Strength Unit mg/mL
Pharmaceutical Classes Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]

Complete Information of Paclitaxel


General Information